The research forecasts the Beta Glucan Market and categorizes report on the basis of market share, market analysis, market trends.
Shopping Cart 0
Cart Subtotal
AED 0

Global Beta Glucan Market-Market share and Industry Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 18350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25690
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

The global market growth is primarily driven due to increasing application of beta-glucan in food industry. Beta Glucan is an essential functional ingredient which has several health benefits such as by utilizing this functional ingredient in order to develop new nutritional products such as oats fibre extract. These products may offer health benefits such as enhancing immune cells beyond basic nutrition. There are several health benefits associated with beta-Glucan are documented in scientific literature that may range from simple stomach problem to complex diseases such as cancer. It focuses on potential sources of beta glucan, such as health implications, industrial applications and immune effect of beta-glucan. In addition, there is also growing application of beta-glucan in food & beverages industry. Major beta glucan sources such yeast, fungi; algae and bacteria make use as functional ingredients in baking, beverage, meat, dairy and confectionary products in food industry. Food retailer Sales in USA has reached USD 1.57 billion in 2015, a 12 percent increase compared to 2014 i.e. 1.40 billion.

However, there are certain factors creating hurdles in the market growth such as inconsistency in regulatory norms of the market. The global market growth is facing crucial challenges such as increase in cost of beta-glucan extraction process the market has huge scope with the unexploited beta-glucan applications in cosmetic and medicine sector

Geographically, Europe is leading the market demand due to increasing food & beverage industry as well as increasing pharmaceutical industry in the region. However, Asia Pacific is also growing with the fastest rate during the forecast period due to increasing demand for beta-glucan in India, China etc. coupled with increasing pharmaceutical industry in the region. The presence of major players such as Cargill Inc, Tate & Lyle PLC, Kerry Group PLC, Koninklijke DSM N.V., Milliporesigma , Specialty Biotech Co. Ltd., Associated British Foods, Chr. Hansen A/S, Alltech Biotechnology etc. These companies used various strategies such as mergers & acquisition, product launches, partnership etc. to enhance their competitiveness across the globe. Tate & Lyle (U.K.), one of the major players in the beta-glucan market, having strategic initiatives such as acquiring new bio-science based companies to focus on the development of modified beta-glucan products and technologies. The company has operation under two division specialty food ingredients and bulk ingredients.

On the basis of market segmentation, the global Beta glucan market is categorized by source, application, and category. Source is further subdivided in bacteria, fungus, yeast, Cereal, algae. On the basis of category it is subdivided in soluble and insoluble nature Beta glucan. On the basis of application it is categorized in Food & Beverages, Personal Care, Pharmaceuticals,and Animal Feed. The use of beta-glucan is increasing in pharmaceutical industry due to increasing use of such compound in cancer medicines as it is effective for reduction in growth of cancer tumor.

READ MORE

Table Of Content

Scope

1. INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

2.1. MARKET DEFINITION AND SCOPE

2.2. EVOLUTION & TRANSITION: GLOBAL BETA GLUCAN MARKET

2.3. REGULATORY FRAMEWORK

2.4. INDUSTRY STRUCTURE

2.5. ESTIMATION ANALYSIS

2.6. TOTAL MARKET ANALYSIS

2.6.1. TOP 5 OPPORTUNITY MARKETS

2.6.2. TOP 5 FINDINGS

2.6.3. TOP 3 COMPETITIVE STRATEGIES

2.6.4. TOP 5 COMPANIES

2.7. COMPETITIVE ANALYSIS

2.7.1. MARKET SHARE ANALYSIS

2.8. STRATEGIC ANALYSIS

2.8.1. SEE-SAW ANALYSIS

2.8.2. 360 DEGREE INDUSTRY ANALYSIS

2.8.3. KEY BUYING CRITERIA AND CONSUMER ANALYSIS

2.8.4. INVESTMENT VS. ADOPTION MODEL

2.8.5. PORTERS FIVE FORCE MODEL

2.9. KEY CONCLUSIONS & STRATEGIC RECOMMENDATIONS

2.9.1. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3. INVESTMENT OPPORTUNITIES BY REGIONS

3. MARKET DETERMINANTS

3.1. DRIVERS & IMPACT ANALYSIS

3.1.1. INCREASING DEMAND FOR PROCESSED AND READY TO EAT FOOD

3.1.2. INCREASED USAGE IN PROCESSED FOODS AS FAT SUBSTITUTES

3.1.3. RISING DISPOSABLE INCOME

3.1.4. GROWING DEMAND FOR YEAST SPECIALTY PRODUCTS

3.2. RESTRAINTS & IMPACT ANALYSIS

3.2.1. VARIOUS SIDE EFFECTS OF CONSUMING BETA GLUCAN

3.2.2. INCONSISTENT REGULATORY STRUCTURE ACROSS COUNTRIES

3.3. OPPORTUNITIES & IMPACT ANALYSIS

3.3.1. EXPANDING FUNCTIONAL FOOD INDUSTRY IN EMERGING ECONOMIES

3.3.2. HIGH USAGE IN NUTRACEUTICAL AND COSMETIC INDUSTRY

3.4. CHALLENGES & IMPACT ANALYSIS

3.4.1. HIGH COST OF BETA-GLUCAN EXTRACTION

3.4.2. SHORTAGE OF MAJOR RAW MATERIALS SUCH AS MOLASSES

4. GLOBAL BETA GLUCAN MARKET BY SOURCE

4.1. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE

4.2. MARKET DEFINITION AND SCOPE

4.3. OPPORTUNITY MATRIX

4.4. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY

4.5. MARKET SEGMENTATION

4.5.1. GLOBAL ALGAE MARKET

4.5.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.1.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.1.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.5.2. GLOBAL BACTERIA MARKET

4.5.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.2.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.2.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.2.4. KEY CONCLUSIONS

4.5.3. GLOBAL CEREAL MARKET

4.5.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.3.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.3.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.3.4. KEY CONCLUSIONS

4.5.4. GLOBAL FUNGUS MARKET

4.5.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.4.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.4.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.4.4. KEY CONCLUSIONS

4.5.5. GLOBAL YEAST MARKET

4.5.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.5.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.5.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.5.4. KEY CONCLUSIONS

5. GLOBAL BETA GLUCAN MARKET BY END USER

5.1. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE

5.2. MARKET DEFINITION AND SCOPE

5.3. OPPORTUNITY MATRIX

5.4. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY

5.5. MARKET SEGMENTATION

5.5.1. GLOBAL ANIMAL FEED MARKET

5.5.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

5.5.1.2. MARKET DETERMINANTS & ADOPTION SCENARIO

5.5.1.3. MARKET PARTICIPANTS AND PRODUCTS

5.5.1.4. KEY CONCLUSIONS

5.5.2. GLOBAL FOOD & BEVERAGES MARKET

5.5.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

5.5.2.2. MARKET DETERMINANTS & ADOPTION SCENARIO

5.5.2.3. MARKET PARTICIPANTS AND PRODUCTS

5.5.2.4. KEY CONCLUSIONS

5.5.3. GLOBAL PERSONAL CARE MARKET

5.5.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

5.5.3.2. MARKET DETERMINANTS & ADOPTION SCENARIO

5.5.3.3. MARKET PARTICIPANTS AND PRODUCTS

5.5.3.4. KEY CONCLUSIONS

5.5.4. GLOBAL PHARMACEUTICALS MARKET

5.5.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

5.5.4.2. MARKET DETERMINANTS & ADOPTION SCENARIO

5.5.4.3. MARKET PARTICIPANTS AND PRODUCTS

5.5.4.4. KEY CONCLUSIONS

6. GLOBAL BETA GLUCAN MARKET BY CATEGORY

6.1. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE

6.2. MARKET DEFINITION AND SCOPE

6.3. OPPORTUNITY MATRIX

6.4. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY

6.5. MARKET SEGMENTATION

6.5.1. GLOBAL INSOLUBLE BETA GLUCAN MARKET

6.5.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

6.5.1.2. MARKET DETERMINANTS & ADOPTION SCENARIO

6.5.1.3. MARKET PARTICIPANTS AND PRODUCTS

6.5.1.4. KEY CONCLUSIONS

6.5.2. GLOBAL SOLUBLE BETA GLUCAN MARKET

6.5.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

6.5.2.2. MARKET DETERMINANTS & ADOPTION SCENARIO

6.5.2.3. MARKET PARTICIPANTS AND PRODUCTS

6.5.2.4. KEY CONCLUSIONS

7. COMPETITIVE LANDSCAPE

7.1. LIST OF KEY STRATEGIES

7.1.1. PARTNERSHIPS LIST

7.1.2. COLLABORATION, MERGERS & ACQUISITION LIST

7.1.3. PRODUCT DEVELOPMENT, PRODUCT LAUNCH LIST

7.1.4. INVESTMENT, EXPANISON, JOINT VENTURES LIST

8. GEOGRAPHIC ANALYSIS

8.1. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY

8.2. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE

8.3. OPPORTUNITY MATRIX

8.4. GLOBAL BETA GLUCAN MARKET BY REGION 205-2024

8.4.1. NORTH AMERICA

8.4.1.1. INDUSTRY ANALYSIS

8.4.1.2. TOP COUNTRY ANALYSIS

8.4.1.2.1. U.S.

8.4.1.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.1.2.1.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.1.2.1.3. KEY CONCLUSIONS

8.4.1.2.2. CANADA

8.4.1.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.1.2.2.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.1.2.2.3. KEY CONCLUSIONS

8.4.2. EUROPE

8.4.2.1. INDUSTRY ANALYSIS

8.4.2.2. TOP COUNTRY ANALYSIS

8.4.2.2.1. UK

8.4.2.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.1.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.1.3. KEY CONCLUSIONS

8.4.2.2.2. FRANCE

8.4.2.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.2.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.2.3. KEY CONCLUSIONS

8.4.2.2.3. GERMANY

8.4.2.2.3.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.3.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.3.3. KEY CONCLUSIONS

8.4.2.2.4. SPAIN

8.4.2.2.4.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.4.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.4.3. KEY CONCLUSIONS

8.4.2.2.5. REST OF EUROPE

8.4.2.2.5.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.5.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.5.3. KEY CONCLUSIONS

8.4.3. ASIA PACIFIC

8.4.3.1. INDUSTRY ANALYSIS

8.4.3.2. TOP COUNTRY ANALYSIS

8.4.3.2.1. CHINA

8.4.3.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.1.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.1.3. KEY CONCLUSIONS

8.4.3.2.2. INDIA

8.4.3.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.2.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.2.3. KEY CONCLUSIONS

8.4.3.2.3. JAPAN

8.4.3.2.3.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.3.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.3.3. KEY CONCLUSIONS

8.4.3.2.4. AUSTRALIA

8.4.3.2.4.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.4.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.4.3. KEY CONCLUSIONS

8.4.3.2.5. REST OF ASIA PACIFIC

8.4.3.2.5.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.5.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.5.3. KEY CONCLUSIONS

8.4.4. ROW

8.4.4.1. INDUSTRY ANALYSIS

8.4.4.2. TOP COUNTRY ANALYSIS

8.4.4.2.1. LATIN AMERICA

8.4.4.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.4.2.1.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.4.2.1.3. KEY CONCLUSIONS

8.4.4.2.2. MIDDLE EAST & AFRICA

8.4.4.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.4.2.2.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.4.2.2.3. KEY CONCLUSIONS

9. COMPANY PROFILES

9.1. ALLTECH BIOTECHNOLOGY (U.S.)

9.1.1. OVERVIEW

9.1.2. PRODUCT PORTFOLIO

9.1.3. STRATEGIC INITIATIVES

9.1.4. SCOT ANALYSIS

9.1.5. STRATEGIC ANALYSIS

9.2. ASSOCIATED BRITISH FOODS PLC (UK.)

9.2.1. OVERVIEW

9.2.2. PRODUCT PORTFOLIO

9.2.3. STRATEGIC INITIATIVES

9.2.4. SCOT ANALYSIS

9.2.5. STRATEGIC ANALYSIS

9.3. BIOTHERA PHARMACEUTICALS INC. (U.S.)

9.3.1. OVERVIEW

9.3.2. PRODUCT PORTFOLIO

9.3.3. STRATEGIC INITIATIVES

9.3.4. SCOT ANALYSIS

9.3.5. STRATEGIC ANALYSIS

9.4. BIOTEC PHARMACON ASA (NORWAY)

9.4.1. OVERVIEW

9.4.2. PRODUCT PORTFOLIO

9.4.3. STRATEGIC INITIATIVES

9.4.4. SCOT ANALYSIS

9.4.5. STRATEGIC ANALYSIS

9.5. CARGILL INC. (U.S.)

9.5.1. OVERVIEW

9.5.2. PRODUCT PORTFOLIO

9.5.3. STRATEGIC INITIATIVES

9.5.4. SCOT ANALYSIS

9.5.5. STRATEGIC ANALYSIS

9.6. CHR. HANSEN A/S. (DENMARK)

9.6.1. OVERVIEW

9.6.2. PRODUCT PORTFOLIO

9.6.3. STRATEGIC INITIATIVES

9.6.4. SCOT ANALYSIS

9.6.5. STRATEGIC ANALYSIS

9.7. DSM N.V. (NETHERLANDS)

9.7.1. OVERVIEW

9.7.2. PRODUCT PORTFOLIO

9.7.3. STRATEGIC INITIATIVES

9.7.4. SCOT ANALYSIS

9.7.5. STRATEGIC ANALYSIS

9.8. LESAFFRE HUMAN CARE (FRANCE)

9.8.1. OVERVIEW

9.8.2. PRODUCT PORTFOLIO

9.8.3. STRATEGIC INITIATIVES

9.8.4. SCOT ANALYSIS

9.8.5. STRATEGIC ANALYSIS

9.9. KERRY GROUP PLC (IRELAND)

9.9.1. OVERVIEW

9.9.2. PRODUCT PORTFOLIO

9.9.3. STRATEGIC INITIATIVES

9.9.4. SCOT ANALYSIS

9.9.5. STRATEGIC ANALYSIS

9.10. MILLIPORESIGMA (U.S.)

9.10.1. OVERVIEW

9.10.2. PRODUCT PORTFOLIO

9.10.3. STRATEGIC INITIATIVES

9.10.4. SCOT ANALYSIS

9.10.5. STRATEGIC ANALYSIS

9.11. OHLY (GERMANY)

9.11.1. OVERVIEW

9.11.2. PRODUCT PORTFOLIO

9.11.3. STRATEGIC INITIATIVES

9.11.4. SCOT ANALYSIS

9.11.5. STRATEGIC ANALYSIS

9.12. PHARMACON ASA (NORWAY)

9.12.1. OVERVIEW

9.12.2. PRODUCT PORTFOLIO

9.12.3. STRATEGIC INITIATIVES

9.12.4. SCOT ANALYSIS

9.12.5. STRATEGIC ANALYSIS

9.13. SPECIALTY BIOTECH CO., LTD (THAILAND)

9.13.1. OVERVIEW

9.13.2. PRODUCT PORTFOLIO

9.13.3. STRATEGIC INITIATIVES

9.13.4. SCOT ANALYSIS

9.13.5. STRATEGIC ANALYSIS

9.14. SUPER BETA GLUCAN (U.S.)

9.14.1. OVERVIEW

9.14.2. PRODUCT PORTFOLIO

9.14.3. STRATEGIC INITIATIVES

9.14.4. SCOT ANALYSIS

9.14.5. STRATEGIC ANALYSIS

9.15. TATE & LYLE PLC (UK)

9.15.1. OVERVIEW

9.15.2. PRODUCT PORTFOLIO

9.15.3. STRATEGIC INITIATIVES

9.15.4. SCOT ANALYSIS

9.15.5. STRATEGIC ANALYSIS

LIST OF TABLES

1. GLOBAL BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

2. GLOBAL ALGAE MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

3. GLOBAL BACTERIA MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

4. GLOBAL CEREAL MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

5. GLOBAL FUNGUS MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

6. GLOBAL YEAST MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

7. GLOBAL BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

8. GLOBAL ANIMAL FEED MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

9. GLOBAL FOOD & BEVERAGES MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

10. GLOBAL PERSONAL CARE MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

11. GLOBAL PHARMACEUTICALS MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

12. GLOBAL BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

13. GLOBAL INSOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

14. GLOBAL SOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

15. GLOBAL BETA GLUCAN MARKET BY REGION 20152024 (USD MILLION)

16. NORTH AMERICA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

17. EUROPE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

18. ASIA PACIFIC BETA GLUCAN MARKET 2015-2024 (USD MILLION)

19. REST OF THE WORLD BETA GLUCAN MARKET 2015-2024 (USD MILLION)

20. NORTH AMERICA BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

21. EUROPE BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

22. ASIA PACIFIC BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

23. REST OF THE WORLD BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

24. NORTH AMERICA BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

25. EUROPE BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

26. ASIA PACIFIC BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

27. REST OF THE WORLD BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

28. NORTH AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

29. EUROPE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

30. ASIA PACIFIC BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

31. REST OF THE WORLD BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

32. UNITED STATES BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

33. CANADA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

34. UK BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

35. GERMANY BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

36. FRANCE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

37. SPAIN BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

38. ROE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

39. CHINA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

40. JAPAN BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

41. AUSTRALIA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

42. ROAPAC BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

43. LATIN AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

44. MENA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

LIST OF FIGURES

1. GLOBAL ALGAE MARKET 2015-2024 (USD MILLION)

2. GLOBAL BACTERIA MARKET 2015-2024 (USD MILLION)

3. GLOBAL CEREAL MARKET 2015-2024 (USD MILLION)

4. GLOBAL FUNGUS MARKET 2015-2024 (USD MILLION)

5. GLOBAL YEAST MARKET 2015-2024 (USD MILLION)

6. GLOBAL ANIMAL FEED MARKET 2015-2024 (USD MILLION)

7. GLOBAL FOOD & BEVERAGES MARKET 2015-2024 (USD MILLION)

8. GLOBAL PERSONAL CARE MARKET 2015-2024 (USD MILLION)

9. GLOBAL PHARMACEUTICALS MARKET 2015-2024 (USD MILLION)

10. GLOBAL INSOLUBLE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

11. GLOBAL SOLUBLE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

12. UNITED STATES (U.S.) BETA GLUCAN MARKET 2015-2024 (USD MILLION)

13. CANADA BETA GLUCAN MARKET2015-2024 (USD MILLION)

14. UNITED KINGDOM (UK) TITANIUM DIOXIDE MARKET2015-2024 (USD MILLION)

15. FRANCE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

16. GERMANY BETA GLUCAN MARKET 2015-2024 (USD MILLION)

17. SPAIN BETA GLUCAN MARKET 2015-2024 (USD MILLION)

18. ITALY BETA GLUCAN MARKET 2015-2024 (USD MILLION)

19. ROE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

20. INDIA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

21. CHINA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

22. JAPAN BETA GLUCAN MARKET 2015-2024 (USD MILLION)

23. KOREA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

24. AUSTRALIA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

25. ROW APAC BETA GLUCAN MARKET 2015-2024 (USD MILLION)

26. LATIN AMERICA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

27. MENA BETA GLUCAN MARKET 2015-2024 (USD MILLION)


List Of Figure

1. GLOBAL ALGAE MARKET 2015-2024 (USD MILLION)

2. GLOBAL BACTERIA MARKET 2015-2024 (USD MILLION)

3. GLOBAL CEREAL MARKET 2015-2024 (USD MILLION)

4. GLOBAL FUNGUS MARKET 2015-2024 (USD MILLION)

5. GLOBAL YEAST MARKET 2015-2024 (USD MILLION)

6. GLOBAL ANIMAL FEED MARKET 2015-2024 (USD MILLION)

7. GLOBAL FOOD & BEVERAGES MARKET 2015-2024 (USD MILLION)

8. GLOBAL PERSONAL CARE MARKET 2015-2024 (USD MILLION)

9. GLOBAL PHARMACEUTICALS MARKET 2015-2024 (USD MILLION)

10. GLOBAL INSOLUBLE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

11. GLOBAL SOLUBLE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

12. UNITED STATES (U.S.) BETA GLUCAN MARKET 2015-2024 (USD MILLION)

13. CANADA BETA GLUCAN MARKET2015-2024 (USD MILLION)

14. UNITED KINGDOM (UK) TITANIUM DIOXIDE MARKET2015-2024 (USD MILLION)

15. FRANCE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

16. GERMANY BETA GLUCAN MARKET 2015-2024 (USD MILLION)

17. SPAIN BETA GLUCAN MARKET 2015-2024 (USD MILLION)

18. ITALY BETA GLUCAN MARKET 2015-2024 (USD MILLION)

19. ROE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

20. INDIA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

21. CHINA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

22. JAPAN BETA GLUCAN MARKET 2015-2024 (USD MILLION)

23. KOREA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

24. AUSTRALIA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

25. ROW APAC BETA GLUCAN MARKET 2015-2024 (USD MILLION)

26. LATIN AMERICA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

27. MENA BETA GLUCAN MARKET 2015-2024 (USD MILLION)


List Of Table

1. GLOBAL BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

2. GLOBAL ALGAE MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

3. GLOBAL BACTERIA MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

4. GLOBAL CEREAL MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

5. GLOBAL FUNGUS MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

6. GLOBAL YEAST MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

7. GLOBAL BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

8. GLOBAL ANIMAL FEED MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

9. GLOBAL FOOD & BEVERAGES MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

10. GLOBAL PERSONAL CARE MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

11. GLOBAL PHARMACEUTICALS MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

12. GLOBAL BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

13. GLOBAL INSOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

14. GLOBAL SOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

15. GLOBAL BETA GLUCAN MARKET BY REGION 20152024 (USD MILLION)

16. NORTH AMERICA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

17. EUROPE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

18. ASIA PACIFIC BETA GLUCAN MARKET 2015-2024 (USD MILLION)

19. REST OF THE WORLD BETA GLUCAN MARKET 2015-2024 (USD MILLION)

20. NORTH AMERICA BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

21. EUROPE BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

22. ASIA PACIFIC BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

23. REST OF THE WORLD BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

24. NORTH AMERICA BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

25. EUROPE BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

26. ASIA PACIFIC BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

27. REST OF THE WORLD BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

28. NORTH AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

29. EUROPE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

30. ASIA PACIFIC BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

31. REST OF THE WORLD BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

32. UNITED STATES BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

33. CANADA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

34. UK BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

35. GERMANY BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

36. FRANCE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

37. SPAIN BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

38. ROE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

39. CHINA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

40. JAPAN BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

41. AUSTRALIA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

42. ROAPAC BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

43. LATIN AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

44. MENA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Global Beta Glucan Market, market research report, glucan, beta glucan foods, industry analysis, beta glucan forecast 2017-2024


Companies

9.1. ALLTECH BIOTECHNOLOGY (U.S.)

9.1.1. OVERVIEW

9.1.2. PRODUCT PORTFOLIO

9.1.3. STRATEGIC INITIATIVES

9.1.4. SCOT ANALYSIS

9.1.5. STRATEGIC ANALYSIS

9.2. ASSOCIATED BRITISH FOODS PLC (UK.)

9.2.1. OVERVIEW

9.2.2. PRODUCT PORTFOLIO

9.2.3. STRATEGIC INITIATIVES

9.2.4. SCOT ANALYSIS

9.2.5. STRATEGIC ANALYSIS

9.3. BIOTHERA PHARMACEUTICALS INC. (U.S.)

9.3.1. OVERVIEW

9.3.2. PRODUCT PORTFOLIO

9.3.3. STRATEGIC INITIATIVES

9.3.4. SCOT ANALYSIS

9.3.5. STRATEGIC ANALYSIS

9.4. BIOTEC PHARMACON ASA (NORWAY)

9.4.1. OVERVIEW

9.4.2. PRODUCT PORTFOLIO

9.4.3. STRATEGIC INITIATIVES

9.4.4. SCOT ANALYSIS

9.4.5. STRATEGIC ANALYSIS

9.5. CARGILL INC. (U.S.)

9.5.1. OVERVIEW

9.5.2. PRODUCT PORTFOLIO

9.5.3. STRATEGIC INITIATIVES

9.5.4. SCOT ANALYSIS

9.5.5. STRATEGIC ANALYSIS

9.6. CHR. HANSEN A/S. (DENMARK)

9.6.1. OVERVIEW

9.6.2. PRODUCT PORTFOLIO

9.6.3. STRATEGIC INITIATIVES

9.6.4. SCOT ANALYSIS

9.6.5. STRATEGIC ANALYSIS

9.7. DSM N.V. (NETHERLANDS)

9.7.1. OVERVIEW

9.7.2. PRODUCT PORTFOLIO

9.7.3. STRATEGIC INITIATIVES

9.7.4. SCOT ANALYSIS

9.7.5. STRATEGIC ANALYSIS

9.8. LESAFFRE HUMAN CARE (FRANCE)

9.8.1. OVERVIEW

9.8.2. PRODUCT PORTFOLIO

9.8.3. STRATEGIC INITIATIVES

9.8.4. SCOT ANALYSIS

9.8.5. STRATEGIC ANALYSIS

9.9. KERRY GROUP PLC (IRELAND)

9.9.1. OVERVIEW

9.9.2. PRODUCT PORTFOLIO

9.9.3. STRATEGIC INITIATIVES

9.9.4. SCOT ANALYSIS

9.9.5. STRATEGIC ANALYSIS

9.10. MILLIPORESIGMA (U.S.)

9.10.1. OVERVIEW

9.10.2. PRODUCT PORTFOLIO

9.10.3. STRATEGIC INITIATIVES

9.10.4. SCOT ANALYSIS

9.10.5. STRATEGIC ANALYSIS

9.11. OHLY (GERMANY)

9.11.1. OVERVIEW

9.11.2. PRODUCT PORTFOLIO

9.11.3. STRATEGIC INITIATIVES

9.11.4. SCOT ANALYSIS

9.11.5. STRATEGIC ANALYSIS

9.12. PHARMACON ASA (NORWAY)

9.12.1. OVERVIEW

9.12.2. PRODUCT PORTFOLIO

9.12.3. STRATEGIC INITIATIVES

9.12.4. SCOT ANALYSIS

9.12.5. STRATEGIC ANALYSIS

9.13. SPECIALTY BIOTECH CO., LTD (THAILAND)

9.13.1. OVERVIEW

9.13.2. PRODUCT PORTFOLIO

9.13.3. STRATEGIC INITIATIVES

9.13.4. SCOT ANALYSIS

9.13.5. STRATEGIC ANALYSIS

9.14. SUPER BETA GLUCAN (U.S.)

9.14.1. OVERVIEW

9.14.2. PRODUCT PORTFOLIO

9.14.3. STRATEGIC INITIATIVES

9.14.4. SCOT ANALYSIS

9.14.5. STRATEGIC ANALYSIS

9.15. TATE & LYLE PLC (UK)

9.15.1. OVERVIEW

9.15.2. PRODUCT PORTFOLIO

9.15.3. STRATEGIC INITIATIVES

9.15.4. SCOT ANALYSIS

9.15.5. STRATEGIC ANALYSIS

The global market growth is primarily driven due to increasing application of beta-glucan in food industry. Beta Glucan is an essential functional ingredient which has several health benefits such as by utilizing this functional ingredient in order to develop new nutritional products such as oats fibre extract. These products may offer health benefits such as enhancing immune cells beyond basic nutrition. There are several health benefits associated with beta-Glucan are documented in scientific literature that may range from simple stomach problem to complex diseases such as cancer. It focuses on potential sources of beta glucan, such as health implications, industrial applications and immune effect of beta-glucan. In addition, there is also growing application of beta-glucan in food & beverages industry. Major beta glucan sources such yeast, fungi; algae and bacteria make use as functional ingredients in baking, beverage, meat, dairy and confectionary products in food industry. Food retailer Sales in USA has reached USD 1.57 billion in 2015, a 12 percent increase compared to 2014 i.e. 1.40 billion.

However, there are certain factors creating hurdles in the market growth such as inconsistency in regulatory norms of the market. The global market growth is facing crucial challenges such as increase in cost of beta-glucan extraction process the market has huge scope with the unexploited beta-glucan applications in cosmetic and medicine sector

Geographically, Europe is leading the market demand due to increasing food & beverage industry as well as increasing pharmaceutical industry in the region. However, Asia Pacific is also growing with the fastest rate during the forecast period due to increasing demand for beta-glucan in India, China etc. coupled with increasing pharmaceutical industry in the region. The presence of major players such as Cargill Inc, Tate & Lyle PLC, Kerry Group PLC, Koninklijke DSM N.V., Milliporesigma , Specialty Biotech Co. Ltd., Associated British Foods, Chr. Hansen A/S, Alltech Biotechnology etc. These companies used various strategies such as mergers & acquisition, product launches, partnership etc. to enhance their competitiveness across the globe. Tate & Lyle (U.K.), one of the major players in the beta-glucan market, having strategic initiatives such as acquiring new bio-science based companies to focus on the development of modified beta-glucan products and technologies. The company has operation under two division specialty food ingredients and bulk ingredients.

On the basis of market segmentation, the global Beta glucan market is categorized by source, application, and category. Source is further subdivided in bacteria, fungus, yeast, Cereal, algae. On the basis of category it is subdivided in soluble and insoluble nature Beta glucan. On the basis of application it is categorized in Food & Beverages, Personal Care, Pharmaceuticals,and Animal Feed. The use of beta-glucan is increasing in pharmaceutical industry due to increasing use of such compound in cancer medicines as it is effective for reduction in growth of cancer tumor.

READ MORE

Scope

1. INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

2.1. MARKET DEFINITION AND SCOPE

2.2. EVOLUTION & TRANSITION: GLOBAL BETA GLUCAN MARKET

2.3. REGULATORY FRAMEWORK

2.4. INDUSTRY STRUCTURE

2.5. ESTIMATION ANALYSIS

2.6. TOTAL MARKET ANALYSIS

2.6.1. TOP 5 OPPORTUNITY MARKETS

2.6.2. TOP 5 FINDINGS

2.6.3. TOP 3 COMPETITIVE STRATEGIES

2.6.4. TOP 5 COMPANIES

2.7. COMPETITIVE ANALYSIS

2.7.1. MARKET SHARE ANALYSIS

2.8. STRATEGIC ANALYSIS

2.8.1. SEE-SAW ANALYSIS

2.8.2. 360 DEGREE INDUSTRY ANALYSIS

2.8.3. KEY BUYING CRITERIA AND CONSUMER ANALYSIS

2.8.4. INVESTMENT VS. ADOPTION MODEL

2.8.5. PORTERS FIVE FORCE MODEL

2.9. KEY CONCLUSIONS & STRATEGIC RECOMMENDATIONS

2.9.1. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3. INVESTMENT OPPORTUNITIES BY REGIONS

3. MARKET DETERMINANTS

3.1. DRIVERS & IMPACT ANALYSIS

3.1.1. INCREASING DEMAND FOR PROCESSED AND READY TO EAT FOOD

3.1.2. INCREASED USAGE IN PROCESSED FOODS AS FAT SUBSTITUTES

3.1.3. RISING DISPOSABLE INCOME

3.1.4. GROWING DEMAND FOR YEAST SPECIALTY PRODUCTS

3.2. RESTRAINTS & IMPACT ANALYSIS

3.2.1. VARIOUS SIDE EFFECTS OF CONSUMING BETA GLUCAN

3.2.2. INCONSISTENT REGULATORY STRUCTURE ACROSS COUNTRIES

3.3. OPPORTUNITIES & IMPACT ANALYSIS

3.3.1. EXPANDING FUNCTIONAL FOOD INDUSTRY IN EMERGING ECONOMIES

3.3.2. HIGH USAGE IN NUTRACEUTICAL AND COSMETIC INDUSTRY

3.4. CHALLENGES & IMPACT ANALYSIS

3.4.1. HIGH COST OF BETA-GLUCAN EXTRACTION

3.4.2. SHORTAGE OF MAJOR RAW MATERIALS SUCH AS MOLASSES

4. GLOBAL BETA GLUCAN MARKET BY SOURCE

4.1. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE

4.2. MARKET DEFINITION AND SCOPE

4.3. OPPORTUNITY MATRIX

4.4. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY

4.5. MARKET SEGMENTATION

4.5.1. GLOBAL ALGAE MARKET

4.5.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.1.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.1.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.1.4. KEY CONCLUSIONS

4.5.2. GLOBAL BACTERIA MARKET

4.5.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.2.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.2.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.2.4. KEY CONCLUSIONS

4.5.3. GLOBAL CEREAL MARKET

4.5.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.3.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.3.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.3.4. KEY CONCLUSIONS

4.5.4. GLOBAL FUNGUS MARKET

4.5.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.4.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.4.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.4.4. KEY CONCLUSIONS

4.5.5. GLOBAL YEAST MARKET

4.5.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

4.5.5.2. MARKET DETERMINANTS & ADOPTION SCENARIO

4.5.5.3. MARKET PARTICIPANTS AND PRODUCTS

4.5.5.4. KEY CONCLUSIONS

5. GLOBAL BETA GLUCAN MARKET BY END USER

5.1. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE

5.2. MARKET DEFINITION AND SCOPE

5.3. OPPORTUNITY MATRIX

5.4. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY

5.5. MARKET SEGMENTATION

5.5.1. GLOBAL ANIMAL FEED MARKET

5.5.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

5.5.1.2. MARKET DETERMINANTS & ADOPTION SCENARIO

5.5.1.3. MARKET PARTICIPANTS AND PRODUCTS

5.5.1.4. KEY CONCLUSIONS

5.5.2. GLOBAL FOOD & BEVERAGES MARKET

5.5.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

5.5.2.2. MARKET DETERMINANTS & ADOPTION SCENARIO

5.5.2.3. MARKET PARTICIPANTS AND PRODUCTS

5.5.2.4. KEY CONCLUSIONS

5.5.3. GLOBAL PERSONAL CARE MARKET

5.5.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

5.5.3.2. MARKET DETERMINANTS & ADOPTION SCENARIO

5.5.3.3. MARKET PARTICIPANTS AND PRODUCTS

5.5.3.4. KEY CONCLUSIONS

5.5.4. GLOBAL PHARMACEUTICALS MARKET

5.5.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

5.5.4.2. MARKET DETERMINANTS & ADOPTION SCENARIO

5.5.4.3. MARKET PARTICIPANTS AND PRODUCTS

5.5.4.4. KEY CONCLUSIONS

6. GLOBAL BETA GLUCAN MARKET BY CATEGORY

6.1. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE

6.2. MARKET DEFINITION AND SCOPE

6.3. OPPORTUNITY MATRIX

6.4. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY

6.5. MARKET SEGMENTATION

6.5.1. GLOBAL INSOLUBLE BETA GLUCAN MARKET

6.5.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

6.5.1.2. MARKET DETERMINANTS & ADOPTION SCENARIO

6.5.1.3. MARKET PARTICIPANTS AND PRODUCTS

6.5.1.4. KEY CONCLUSIONS

6.5.2. GLOBAL SOLUBLE BETA GLUCAN MARKET

6.5.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 (USD MILLION)

6.5.2.2. MARKET DETERMINANTS & ADOPTION SCENARIO

6.5.2.3. MARKET PARTICIPANTS AND PRODUCTS

6.5.2.4. KEY CONCLUSIONS

7. COMPETITIVE LANDSCAPE

7.1. LIST OF KEY STRATEGIES

7.1.1. PARTNERSHIPS LIST

7.1.2. COLLABORATION, MERGERS & ACQUISITION LIST

7.1.3. PRODUCT DEVELOPMENT, PRODUCT LAUNCH LIST

7.1.4. INVESTMENT, EXPANISON, JOINT VENTURES LIST

8. GEOGRAPHIC ANALYSIS

8.1. MARKET SEGMENT ANALYSIS A COMPARATIVE STUDY

8.2. ESTIMATION METHODOLOGY & DECISION BACKING DATABASE

8.3. OPPORTUNITY MATRIX

8.4. GLOBAL BETA GLUCAN MARKET BY REGION 205-2024

8.4.1. NORTH AMERICA

8.4.1.1. INDUSTRY ANALYSIS

8.4.1.2. TOP COUNTRY ANALYSIS

8.4.1.2.1. U.S.

8.4.1.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.1.2.1.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.1.2.1.3. KEY CONCLUSIONS

8.4.1.2.2. CANADA

8.4.1.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.1.2.2.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.1.2.2.3. KEY CONCLUSIONS

8.4.2. EUROPE

8.4.2.1. INDUSTRY ANALYSIS

8.4.2.2. TOP COUNTRY ANALYSIS

8.4.2.2.1. UK

8.4.2.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.1.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.1.3. KEY CONCLUSIONS

8.4.2.2.2. FRANCE

8.4.2.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.2.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.2.3. KEY CONCLUSIONS

8.4.2.2.3. GERMANY

8.4.2.2.3.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.3.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.3.3. KEY CONCLUSIONS

8.4.2.2.4. SPAIN

8.4.2.2.4.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.4.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.4.3. KEY CONCLUSIONS

8.4.2.2.5. REST OF EUROPE

8.4.2.2.5.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.2.2.5.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.5.3. KEY CONCLUSIONS

8.4.3. ASIA PACIFIC

8.4.3.1. INDUSTRY ANALYSIS

8.4.3.2. TOP COUNTRY ANALYSIS

8.4.3.2.1. CHINA

8.4.3.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.1.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.1.3. KEY CONCLUSIONS

8.4.3.2.2. INDIA

8.4.3.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.2.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.2.3. KEY CONCLUSIONS

8.4.3.2.3. JAPAN

8.4.3.2.3.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.3.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.3.3. KEY CONCLUSIONS

8.4.3.2.4. AUSTRALIA

8.4.3.2.4.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.4.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.4.3. KEY CONCLUSIONS

8.4.3.2.5. REST OF ASIA PACIFIC

8.4.3.2.5.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.3.2.5.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.5.3. KEY CONCLUSIONS

8.4.4. ROW

8.4.4.1. INDUSTRY ANALYSIS

8.4.4.2. TOP COUNTRY ANALYSIS

8.4.4.2.1. LATIN AMERICA

8.4.4.2.1.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.4.2.1.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.4.2.1.3. KEY CONCLUSIONS

8.4.4.2.2. MIDDLE EAST & AFRICA

8.4.4.2.2.1. MARKET FORECASTS AND ESTIMATION 2015-2024 (USD MILLION)

8.4.4.2.2.2. MARKET PARTICIPANTS AND PRODUCTS

8.4.4.2.2.3. KEY CONCLUSIONS

9. COMPANY PROFILES

9.1. ALLTECH BIOTECHNOLOGY (U.S.)

9.1.1. OVERVIEW

9.1.2. PRODUCT PORTFOLIO

9.1.3. STRATEGIC INITIATIVES

9.1.4. SCOT ANALYSIS

9.1.5. STRATEGIC ANALYSIS

9.2. ASSOCIATED BRITISH FOODS PLC (UK.)

9.2.1. OVERVIEW

9.2.2. PRODUCT PORTFOLIO

9.2.3. STRATEGIC INITIATIVES

9.2.4. SCOT ANALYSIS

9.2.5. STRATEGIC ANALYSIS

9.3. BIOTHERA PHARMACEUTICALS INC. (U.S.)

9.3.1. OVERVIEW

9.3.2. PRODUCT PORTFOLIO

9.3.3. STRATEGIC INITIATIVES

9.3.4. SCOT ANALYSIS

9.3.5. STRATEGIC ANALYSIS

9.4. BIOTEC PHARMACON ASA (NORWAY)

9.4.1. OVERVIEW

9.4.2. PRODUCT PORTFOLIO

9.4.3. STRATEGIC INITIATIVES

9.4.4. SCOT ANALYSIS

9.4.5. STRATEGIC ANALYSIS

9.5. CARGILL INC. (U.S.)

9.5.1. OVERVIEW

9.5.2. PRODUCT PORTFOLIO

9.5.3. STRATEGIC INITIATIVES

9.5.4. SCOT ANALYSIS

9.5.5. STRATEGIC ANALYSIS

9.6. CHR. HANSEN A/S. (DENMARK)

9.6.1. OVERVIEW

9.6.2. PRODUCT PORTFOLIO

9.6.3. STRATEGIC INITIATIVES

9.6.4. SCOT ANALYSIS

9.6.5. STRATEGIC ANALYSIS

9.7. DSM N.V. (NETHERLANDS)

9.7.1. OVERVIEW

9.7.2. PRODUCT PORTFOLIO

9.7.3. STRATEGIC INITIATIVES

9.7.4. SCOT ANALYSIS

9.7.5. STRATEGIC ANALYSIS

9.8. LESAFFRE HUMAN CARE (FRANCE)

9.8.1. OVERVIEW

9.8.2. PRODUCT PORTFOLIO

9.8.3. STRATEGIC INITIATIVES

9.8.4. SCOT ANALYSIS

9.8.5. STRATEGIC ANALYSIS

9.9. KERRY GROUP PLC (IRELAND)

9.9.1. OVERVIEW

9.9.2. PRODUCT PORTFOLIO

9.9.3. STRATEGIC INITIATIVES

9.9.4. SCOT ANALYSIS

9.9.5. STRATEGIC ANALYSIS

9.10. MILLIPORESIGMA (U.S.)

9.10.1. OVERVIEW

9.10.2. PRODUCT PORTFOLIO

9.10.3. STRATEGIC INITIATIVES

9.10.4. SCOT ANALYSIS

9.10.5. STRATEGIC ANALYSIS

9.11. OHLY (GERMANY)

9.11.1. OVERVIEW

9.11.2. PRODUCT PORTFOLIO

9.11.3. STRATEGIC INITIATIVES

9.11.4. SCOT ANALYSIS

9.11.5. STRATEGIC ANALYSIS

9.12. PHARMACON ASA (NORWAY)

9.12.1. OVERVIEW

9.12.2. PRODUCT PORTFOLIO

9.12.3. STRATEGIC INITIATIVES

9.12.4. SCOT ANALYSIS

9.12.5. STRATEGIC ANALYSIS

9.13. SPECIALTY BIOTECH CO., LTD (THAILAND)

9.13.1. OVERVIEW

9.13.2. PRODUCT PORTFOLIO

9.13.3. STRATEGIC INITIATIVES

9.13.4. SCOT ANALYSIS

9.13.5. STRATEGIC ANALYSIS

9.14. SUPER BETA GLUCAN (U.S.)

9.14.1. OVERVIEW

9.14.2. PRODUCT PORTFOLIO

9.14.3. STRATEGIC INITIATIVES

9.14.4. SCOT ANALYSIS

9.14.5. STRATEGIC ANALYSIS

9.15. TATE & LYLE PLC (UK)

9.15.1. OVERVIEW

9.15.2. PRODUCT PORTFOLIO

9.15.3. STRATEGIC INITIATIVES

9.15.4. SCOT ANALYSIS

9.15.5. STRATEGIC ANALYSIS

LIST OF TABLES

1. GLOBAL BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

2. GLOBAL ALGAE MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

3. GLOBAL BACTERIA MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

4. GLOBAL CEREAL MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

5. GLOBAL FUNGUS MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

6. GLOBAL YEAST MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

7. GLOBAL BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

8. GLOBAL ANIMAL FEED MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

9. GLOBAL FOOD & BEVERAGES MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

10. GLOBAL PERSONAL CARE MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

11. GLOBAL PHARMACEUTICALS MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

12. GLOBAL BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

13. GLOBAL INSOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

14. GLOBAL SOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

15. GLOBAL BETA GLUCAN MARKET BY REGION 20152024 (USD MILLION)

16. NORTH AMERICA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

17. EUROPE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

18. ASIA PACIFIC BETA GLUCAN MARKET 2015-2024 (USD MILLION)

19. REST OF THE WORLD BETA GLUCAN MARKET 2015-2024 (USD MILLION)

20. NORTH AMERICA BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

21. EUROPE BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

22. ASIA PACIFIC BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

23. REST OF THE WORLD BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

24. NORTH AMERICA BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

25. EUROPE BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

26. ASIA PACIFIC BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

27. REST OF THE WORLD BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

28. NORTH AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

29. EUROPE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

30. ASIA PACIFIC BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

31. REST OF THE WORLD BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

32. UNITED STATES BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

33. CANADA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

34. UK BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

35. GERMANY BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

36. FRANCE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

37. SPAIN BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

38. ROE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

39. CHINA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

40. JAPAN BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

41. AUSTRALIA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

42. ROAPAC BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

43. LATIN AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

44. MENA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

LIST OF FIGURES

1. GLOBAL ALGAE MARKET 2015-2024 (USD MILLION)

2. GLOBAL BACTERIA MARKET 2015-2024 (USD MILLION)

3. GLOBAL CEREAL MARKET 2015-2024 (USD MILLION)

4. GLOBAL FUNGUS MARKET 2015-2024 (USD MILLION)

5. GLOBAL YEAST MARKET 2015-2024 (USD MILLION)

6. GLOBAL ANIMAL FEED MARKET 2015-2024 (USD MILLION)

7. GLOBAL FOOD & BEVERAGES MARKET 2015-2024 (USD MILLION)

8. GLOBAL PERSONAL CARE MARKET 2015-2024 (USD MILLION)

9. GLOBAL PHARMACEUTICALS MARKET 2015-2024 (USD MILLION)

10. GLOBAL INSOLUBLE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

11. GLOBAL SOLUBLE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

12. UNITED STATES (U.S.) BETA GLUCAN MARKET 2015-2024 (USD MILLION)

13. CANADA BETA GLUCAN MARKET2015-2024 (USD MILLION)

14. UNITED KINGDOM (UK) TITANIUM DIOXIDE MARKET2015-2024 (USD MILLION)

15. FRANCE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

16. GERMANY BETA GLUCAN MARKET 2015-2024 (USD MILLION)

17. SPAIN BETA GLUCAN MARKET 2015-2024 (USD MILLION)

18. ITALY BETA GLUCAN MARKET 2015-2024 (USD MILLION)

19. ROE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

20. INDIA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

21. CHINA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

22. JAPAN BETA GLUCAN MARKET 2015-2024 (USD MILLION)

23. KOREA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

24. AUSTRALIA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

25. ROW APAC BETA GLUCAN MARKET 2015-2024 (USD MILLION)

26. LATIN AMERICA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

27. MENA BETA GLUCAN MARKET 2015-2024 (USD MILLION)


List Of Figure

1. GLOBAL ALGAE MARKET 2015-2024 (USD MILLION)

2. GLOBAL BACTERIA MARKET 2015-2024 (USD MILLION)

3. GLOBAL CEREAL MARKET 2015-2024 (USD MILLION)

4. GLOBAL FUNGUS MARKET 2015-2024 (USD MILLION)

5. GLOBAL YEAST MARKET 2015-2024 (USD MILLION)

6. GLOBAL ANIMAL FEED MARKET 2015-2024 (USD MILLION)

7. GLOBAL FOOD & BEVERAGES MARKET 2015-2024 (USD MILLION)

8. GLOBAL PERSONAL CARE MARKET 2015-2024 (USD MILLION)

9. GLOBAL PHARMACEUTICALS MARKET 2015-2024 (USD MILLION)

10. GLOBAL INSOLUBLE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

11. GLOBAL SOLUBLE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

12. UNITED STATES (U.S.) BETA GLUCAN MARKET 2015-2024 (USD MILLION)

13. CANADA BETA GLUCAN MARKET2015-2024 (USD MILLION)

14. UNITED KINGDOM (UK) TITANIUM DIOXIDE MARKET2015-2024 (USD MILLION)

15. FRANCE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

16. GERMANY BETA GLUCAN MARKET 2015-2024 (USD MILLION)

17. SPAIN BETA GLUCAN MARKET 2015-2024 (USD MILLION)

18. ITALY BETA GLUCAN MARKET 2015-2024 (USD MILLION)

19. ROE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

20. INDIA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

21. CHINA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

22. JAPAN BETA GLUCAN MARKET 2015-2024 (USD MILLION)

23. KOREA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

24. AUSTRALIA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

25. ROW APAC BETA GLUCAN MARKET 2015-2024 (USD MILLION)

26. LATIN AMERICA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

27. MENA BETA GLUCAN MARKET 2015-2024 (USD MILLION)


List Of Table

1. GLOBAL BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

2. GLOBAL ALGAE MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

3. GLOBAL BACTERIA MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

4. GLOBAL CEREAL MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

5. GLOBAL FUNGUS MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

6. GLOBAL YEAST MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

7. GLOBAL BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

8. GLOBAL ANIMAL FEED MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

9. GLOBAL FOOD & BEVERAGES MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

10. GLOBAL PERSONAL CARE MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

11. GLOBAL PHARMACEUTICALS MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

12. GLOBAL BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

13. GLOBAL INSOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

14. GLOBAL SOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2015-2024 (USD MILLION)

15. GLOBAL BETA GLUCAN MARKET BY REGION 20152024 (USD MILLION)

16. NORTH AMERICA BETA GLUCAN MARKET 2015-2024 (USD MILLION)

17. EUROPE BETA GLUCAN MARKET 2015-2024 (USD MILLION)

18. ASIA PACIFIC BETA GLUCAN MARKET 2015-2024 (USD MILLION)

19. REST OF THE WORLD BETA GLUCAN MARKET 2015-2024 (USD MILLION)

20. NORTH AMERICA BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

21. EUROPE BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

22. ASIA PACIFIC BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

23. REST OF THE WORLD BETA GLUCAN MARKET BY SOURCE 2015-2024 (USD MILLION)

24. NORTH AMERICA BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

25. EUROPE BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

26. ASIA PACIFIC BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

27. REST OF THE WORLD BETA GLUCAN MARKET BY END USER 2015-2024 (USD MILLION)

28. NORTH AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

29. EUROPE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

30. ASIA PACIFIC BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

31. REST OF THE WORLD BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

32. UNITED STATES BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

33. CANADA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

34. UK BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

35. GERMANY BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

36. FRANCE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

37. SPAIN BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

38. ROE BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

39. CHINA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

40. JAPAN BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

41. AUSTRALIA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

42. ROAPAC BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

43. LATIN AMERICA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

44. MENA BETA GLUCAN MARKET BY CATEGORY 2015-2024 (USD MILLION)

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Global Beta Glucan Market, market research report, glucan, beta glucan foods, industry analysis, beta glucan forecast 2017-2024


Companies

9.1. ALLTECH BIOTECHNOLOGY (U.S.)

9.1.1. OVERVIEW

9.1.2. PRODUCT PORTFOLIO

9.1.3. STRATEGIC INITIATIVES

9.1.4. SCOT ANALYSIS

9.1.5. STRATEGIC ANALYSIS

9.2. ASSOCIATED BRITISH FOODS PLC (UK.)

9.2.1. OVERVIEW

9.2.2. PRODUCT PORTFOLIO

9.2.3. STRATEGIC INITIATIVES

9.2.4. SCOT ANALYSIS

9.2.5. STRATEGIC ANALYSIS

9.3. BIOTHERA PHARMACEUTICALS INC. (U.S.)

9.3.1. OVERVIEW

9.3.2. PRODUCT PORTFOLIO

9.3.3. STRATEGIC INITIATIVES

9.3.4. SCOT ANALYSIS

9.3.5. STRATEGIC ANALYSIS

9.4. BIOTEC PHARMACON ASA (NORWAY)

9.4.1. OVERVIEW

9.4.2. PRODUCT PORTFOLIO

9.4.3. STRATEGIC INITIATIVES

9.4.4. SCOT ANALYSIS

9.4.5. STRATEGIC ANALYSIS

9.5. CARGILL INC. (U.S.)

9.5.1. OVERVIEW

9.5.2. PRODUCT PORTFOLIO

9.5.3. STRATEGIC INITIATIVES

9.5.4. SCOT ANALYSIS

9.5.5. STRATEGIC ANALYSIS

9.6. CHR. HANSEN A/S. (DENMARK)

9.6.1. OVERVIEW

9.6.2. PRODUCT PORTFOLIO

9.6.3. STRATEGIC INITIATIVES

9.6.4. SCOT ANALYSIS

9.6.5. STRATEGIC ANALYSIS

9.7. DSM N.V. (NETHERLANDS)

9.7.1. OVERVIEW

9.7.2. PRODUCT PORTFOLIO

9.7.3. STRATEGIC INITIATIVES

9.7.4. SCOT ANALYSIS

9.7.5. STRATEGIC ANALYSIS

9.8. LESAFFRE HUMAN CARE (FRANCE)

9.8.1. OVERVIEW

9.8.2. PRODUCT PORTFOLIO

9.8.3. STRATEGIC INITIATIVES

9.8.4. SCOT ANALYSIS

9.8.5. STRATEGIC ANALYSIS

9.9. KERRY GROUP PLC (IRELAND)

9.9.1. OVERVIEW

9.9.2. PRODUCT PORTFOLIO

9.9.3. STRATEGIC INITIATIVES

9.9.4. SCOT ANALYSIS

9.9.5. STRATEGIC ANALYSIS

9.10. MILLIPORESIGMA (U.S.)

9.10.1. OVERVIEW

9.10.2. PRODUCT PORTFOLIO

9.10.3. STRATEGIC INITIATIVES

9.10.4. SCOT ANALYSIS

9.10.5. STRATEGIC ANALYSIS

9.11. OHLY (GERMANY)

9.11.1. OVERVIEW

9.11.2. PRODUCT PORTFOLIO

9.11.3. STRATEGIC INITIATIVES

9.11.4. SCOT ANALYSIS

9.11.5. STRATEGIC ANALYSIS

9.12. PHARMACON ASA (NORWAY)

9.12.1. OVERVIEW

9.12.2. PRODUCT PORTFOLIO

9.12.3. STRATEGIC INITIATIVES

9.12.4. SCOT ANALYSIS

9.12.5. STRATEGIC ANALYSIS

9.13. SPECIALTY BIOTECH CO., LTD (THAILAND)

9.13.1. OVERVIEW

9.13.2. PRODUCT PORTFOLIO

9.13.3. STRATEGIC INITIATIVES

9.13.4. SCOT ANALYSIS

9.13.5. STRATEGIC ANALYSIS

9.14. SUPER BETA GLUCAN (U.S.)

9.14.1. OVERVIEW

9.14.2. PRODUCT PORTFOLIO

9.14.3. STRATEGIC INITIATIVES

9.14.4. SCOT ANALYSIS

9.14.5. STRATEGIC ANALYSIS

9.15. TATE & LYLE PLC (UK)

9.15.1. OVERVIEW

9.15.2. PRODUCT PORTFOLIO

9.15.3. STRATEGIC INITIATIVES

9.15.4. SCOT ANALYSIS

9.15.5. STRATEGIC ANALYSIS